IJSTR

International Journal of Scientific & Technology Research

IJSTR@Facebook IJSTR@Twitter IJSTR@Linkedin
Home About Us Scope Editorial Board Blog/Latest News Contact Us
Scopus/Elsevier
CALL FOR PAPERS
AUTHORS
DOWNLOADS
CONTACT
QR CODE
IJSTR-QR Code

IJSTR >> Volume 7 - Issue 2, February 2018 Edition



International Journal of Scientific & Technology Research  
International Journal of Scientific & Technology Research

Website: http://www.ijstr.org

ISSN 2277-8616



Perfluorocarbons As A Blood In Future

[Full Text]

 

AUTHOR(S)

Y. Praveen Kumar

 

KEYWORDS

N/A

 

ABSTRACT

Many people are losing their lives because of lack in supply of proper blood in right time. After collecting the blood from a donor a serious attention must be given to each unit of blood; proper typing, screening for pathogenic organisms & storing at proper temperature. Lack of attentiveness in these areas will make the blood useless, to overcome this situation, a viable blood substitute is needed. Perflurocorbons when used as a blood substitute doesn’t need typing, screening tests for pathogenic organisms, and also perflurocorbons increases the rate of transport of oxygen. So it can be used as a blood substitute.

 

REFERENCES

[1] Hematology AS of. Blood Basics. Blood Basics.

[2] Bennett-Guerrero E, Zhao Y, O’Brien SM, et al. Variation in Use of Blood Transfusion in Coronary Artery Bypass Graft Surgery. JAMA. 2010;304(14):1568. doi:10.1001/jama.2010.1406.

[3] R KV, P BD, S IR. A REVIEW ON ARTIFICIAL BLOOD: A SOURCE WE NEED. Asian J Pharm Clin Res. 2017;10(9):38. doi:10.22159/ajpcr.2017.v10i9.18960.

[4] Park S-Y, Seo K-S, Karm M-H. Perioperative red blood cell transfusion in orofacial surgery. J Dent Anesth pain Med. 2017;17(3):163-181. doi:10.17245/jdapm.2017.17.3.163.

[5] Schmidt PJ, Ness PM. Hemotherapy: from bloodletting magic to transfusion medicine. Transfusion. 2006;46(2):166-168. doi:10.1111/j.1537-2995.2006.00697.x.

[6] Sitharaman B. Nanobiomaterials Handbook. CRC Press; 2011.

[7] Technology H, Unit A, Division MD, Of M. Artificial Blood Health Technology Assessment Unit Medical Development Division.; 2007.

[8] Arash Ramedani MM, Yazdanpanah A, Yazdanpanah A. Artificial Blood- A Game Changer for Future Medicine: Where are we Today? J Blood Disord Transfus. 2015;6(5). doi:10.4172/2155-9864.1000312.

[9] Spahn D, Kocian R. Artificial O2 Carriers: Status in 2005. Curr Pharm Des. 2005;11(31):4099-4114. doi:10.2174/138161205774913354.

[10] Moore EE. Blood substitutes: the future is now. J Am Coll Surg. 2003;196(1):1-17. doi:10.1016/S1072-7515(02)01704-0.

[11] Anbari KK, Garino JP, Mackenzie CF. Hemoglobin substitutes. Eur Spine J. 2004;13 Suppl 1(Suppl 1):S76-82. doi:10.1007/s00586-004-0737-x.

[12] American Society of Anesthesiologists. KK. Anesthesiology. Vol 97. [American Society of Anesthesiologists, etc.]; 2002.

[13] Greer JP, Arber DA, Glader B, et al. Wintrobe’s Clinical Hematology. Wolters Kluwer Health Adis (ESP); 2013.

[14] Spahn DR. Blood substitutes. Artificial oxygen carriers: perfluorocarbon emulsions. Crit Care. 1999;3(5):R93-7. doi:10.1186/cc364.

[15] Vorob’ev SI. First- and second-generation perfluorocarbon emulsions. Pharm Chem J. 2009;43(4):209-218. doi:10.1007/s11094-009-0268-1.

[16] Faithfull NS. Oxygen delivery from fluorocarbon emulsions--aspects of convective and diffusive transport. Biomater Artif Cells Immobilization Biotechnol. 1992;20(2-4):797-804.